CELLO.NS(CELLO.NS)
CELLO.NS
No analyst ratings available
No analyst price targets available for CELLO.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $25.99B | $29.08B | $33.78B |
| Low | $25.22B | $27.39B | $32.27B |
| High | $26.72B | $30.78B | $35.27B |
| EBITDA Avg | $6.29B | $7.04B | $8.18B |
| Low | $6.11B | $6.63B | $7.82B |
| High | $6.47B | $7.46B | $8.54B |
| EBIT Avg | $5.49B | $6.15B | $7.14B |
| Low | $5.33B | $5.79B | $6.82B |
| High | $5.65B | $6.51B | $7.45B |
| Net Income Avg | $3.70B | $4.42B | $5.22B |
| Low | $3.35B | $4.25B | $4.78B |
| High | $4.38B | $5.07B | $5.66B |
| EPS Avg | $17.32 | $20.60 | $23.15 |
| Low | $14.84 | $18.85 | $21.20 |
| High | $19.41 | $22.47 | $25.10 |
| Analysts (Rev / EPS) | 8 / 8 | 8 / 8 | 2 / 2 |